The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...

HealthEquity (HQY) reports strong Q1 2026 growth with increased revenue, reduced fraud costs, and advancements in AI and mobile tech.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

In Medicare Advantage, UnitedHealth holds a firm advantage, having increased its market share from 25% in 2017 to 29% in 2023. For comparison, Humana (NYSE: HUM) holds 18% market share in both periods ...

Per WSJ’s forecasting data, the average UNH price target is $378.86 per share. Given that the current UNH price is $292.80 ...

Shares of health insurance company Humana (NYSE:HUM) fell 6.5% in the afternoon session after the Centers for Medicare & ...

Humana maintains a healthy balance sheet, in our opinion. Most of its cash and investments ($24 billion as of mid-2024) is held at its subsidiaries, though, and the company aims to hold about $500 ...

WASHINGTON-House Republicans made a series of last-minute changes to their sprawling tax-and-spending bill, searching for a path that could unite the party's warring wings headed into a nail-biter ...

Palo Alto Networks reported better-than-expected earnings and revenue for the latest quarter but its gross margin was below estimates. The stock dropped 4% in extended trading on Tuesday.

Humana recently reported robust first-quarter earnings with significant ... Unlock comprehensive insights into our analysis of Humana stock in this financial health report.